NCT02798315View on ClinicalTrials.gov

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 25, 2016

Primary Completion Date

June 12, 2017

Study Completion Date

June 12, 2017

Conditions
Chronic Hepatitis C
Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY